Introduction of Biopharmaceutical and Medical Equipment/Device Industrial Cluster in San Diego, leveraging existing networks, and support to Japanese companies who are planning to enter the US market.

100000:0000:::::::00000000~~~~~~200000:00000::::::::00

Venue PACIFICO YOKOHAMA Annex Hall F201+F202

Fee Seminar fee: JPY 60,000 + tax　　Reception Party fee: JPY 5,000 + tax

Language Japanese / English (simultaneous interpretation to Japanese)

221

Sponsored by CM Plus CorporationUnder the auspices of the Municipality of Yokohama CityFor inquiry：　“Fast Pass to US Market for Life-Science Industry” Person in charge : S.Takada　　　　　TEL：+81-45-222-8710　Mail： seminar@m.cm-plus.co.jp

Lecture　10:00-15:40　　-Lecture_1：　Pharmaceutical Industry and Medical Device/Equipment Industry’s Global Strategy　　-Lecture_2：　Winning in US Biopharma M&A　　-Lecture_3：　Radically Changing Pharmaceutical Industry ‒ Pharmaceutical Companies’ Strategy for Survival　　-Lecture_4：　Approaches, Challenges and Benefits for Japanese Life-science Companies entering the US Market　　-Lecture_5：　Technology and Trends of Healthcare Solutions Adapting to Digital Health

Panel Discussion 15:45-17:45 ---How to Promote Business Matching and US Market Entry for Japanese Companies; the “Fast Pass” to the US Market---

Reception Party 18:00-20:00 【participation voluntary】

Program

Norikazu Eiki Advisor to CM PlusCorporation

Rich Yang 　CEO, Sharp Life Science (North America)

※The content of lecturer / program may change.

Part ic ipants :120 personsApplication may be closed before the closing date if the number is fully booked

Date and t ime:23rd April 2018 Seminar 10:00-18:00Reception Party 18:00-20:00 (participation voluntary)

Appl icat ion Closing Date:13th April 2018

Venue:PACIFICO YOKOHAMA Annex Hall F201+F2021-1-1, Minato Mirai, Nishi-ku, Yokohama 220-0012, JAPAN

5 minutes on foot from Minato Mirai Station

http://www.pacifico.co.jp/english/destination/access/tabid/502/Default.aspx

Fees (excluding tax)Seminar participation fee: JPY 60,000Reception Party fee: JPY 5,000※No handouts of the lecture materials available

Notes① After receipt of an invoice from us, please pay the fees to our bank account within 5 days but not later than the seminar.② Only those who paid the fee in advance may attend the Reception Party after the seminar.③ If you are interested in the free matching consultation on 14th April, please fill out the format and designate a lecturer or a panelist whom you wish to talk with. A time for the consultation will be fixed and informed to you beforehand.④ The application may be cancelled without any charge before 13th April. No late advice of cancellation will be entertained.⑤ Upon the seminar day, the participants will be received against presentation of the business card as ID. ⑥ The content of the seminar program may be changed without any pre-notice.⑦ No handouts will be provided for any lectures.

For inquiry

Business with Business Minatomirai Grand Central Tower 6F, 4-6-2, Minatomirai, Nishi-ku, Yokohama 220-0012, Japan

Application Guidelines for Seminar

Kentaro KishimotoMinistry of Economy, Trade and Industry

Donald Rindell 　M.D., Camino International, LLC

23rd April, 2018

※No handouts for the lecture materials.

Fast Pass to US Marketfor Life-Science Industry

Mail: seminar@m.cm-plus.co.jpTell +81-45-222-8710( Person in-charge : S.Takada)

CM Plus Corporation

Raymond Chan 　McKinsey & Company, Inc. Japan

Bruce Myrehn 　President, StS, LLC

Fast Pass to US Market for Life-Science Industry

Program Profile10:00-10:10 Greeting from the Municipality of Yokohama City （Lip Yokohama）　10:10-11:00 Lecture 1: Pharmaceutical Industry and Medical Device/ Equipment Industry’s Global Strategy （Mr. Kentaro Kishimoto）

11:00-11:50 Lecture 2: Winning in US Biopharma M&A （Dr. Raymond Chan）

11:50-12:50 Lunch Break (a packed lunch will be served)

12:50-13:40 Lecture 3: Radically Changing Pharmaceutical Industry ‒ Pharmaceutical Companies’ Strategy for Survival‒ （Mr. Norikazu Eiki）

13:40-14:30 Lecture 4: Approaches, Challenges and Benefits for Japanese Life-science Companies Entering the US Market (Mr. Donald Rindell）

14:30-14:50 Intermission

14:50-15:40 Lecture 5: Technology and Trends of Healthcare Solutions (Pharmaceutical and Medical Device) Adapting to Digital Health. （Rich Yang)

15:45-17:45 Panel Discussion　　　　 　　　　　―How to Promote Business Matching and US Market Entry for Japanese Companies; a “Fast Pass” to the US Market̶

Panelists: ① Donald Rindell ② Norikazu Eiki ③ Will Clodfelter ④ Christopher Rhodes Facilitator 　Bruce Myrehn

17:45-17:55 Closing Speech 　18:00-20:00 Reception Party (Buffet Supper)

Consulting24th April, 2018

Following the seminar, a free consulting opportunity with CM plus and a designated consultant will be provided on the next day (24th April) at the Office of CM Plus for the first 15 voluntary applicants. The applicants shall therefore fill out the preliminary questionnaire form attached to this program, so that a non-disclosure agreement should be given to each applicant by CM Plus.

What is Trust Network?Trust Network is a network of companies and consultants that are proven to be reliable and competent in a specific business area.

Our Trust Network will serve as “Fast Pass” to enter the US Market, i f you wish to;

What is Trust Network?at WWha Truis k?wot N orkNetusuWWWWWTruruTr sts Network is a network of coruurTT worNe rketwsts orknetis twoa nkk of ccok oTconnsullsu tanta ts that are proven to bco thaantsulsu ats tltaton proaree pt at bn ttovecompettentnten in a specific businessesp inetteeom pen a nntmpec cifiece nesbus sssinc b

OuOurOuur TrTrust NeNetwtwork will serve as O orNeNerusuruuu twwst NTrTOOOOO lwill lk w asserl s vel sl lif fif i f youououuyy wwish to;o;f yiffi y o;o;ishuuuouf h towwiyyf yyifififiiii fi

Support

Business Development

CRORegulatory

ClinicalOther

US top-level consultants and matching guides

Trust Network

Mr. Christopher Rhodes 　President and CEO at Drug Delivery Experts

Mr. Will ClodfelterChief Executive Officer at Medicus Biosciences

Mr. Bruce Myrehn　President, StS, LLC

Majored in both mechanical engineering and economics. He worked for a mega-pharma in the US over 32 years, including such professional experience as a program director, an adviser for engineering/manufacturing, a six sigma master blackbelt, a manager of operations, a manager of QA/QC and a site head of a plant in Japan.

【Panelists】

Mr. Rich Yang CEO of Sharp Life Science (North America)

Leader in Business Development in the life science; US, Japan, AsiaInternational expertise representing technol-ogy and business development in the fields of biotech, device, diagnostic, and technology enabled health and wellness integration.

Mr. Kentaro KishimotoDirector, International Business Promotion OfficeHealthcare Industries Division,Commerce and Service Industry Group,the Ministry of Economy, Trade and Industry

In 2000 Joined the Ministry of Health and Welfare Evaluation and Licensing Division and Blood and Blood Products Division, Pharmaceutical Safety Bureau, and Medical Economics Division, Health Insurance Bureau Deputy Director, Office for Integra-tion of Consumer Policy, Cabinet Secretariat. He is an incumbent since July 2017.

Mr. Donald Rindell Managing Director, Camino International, LLC

Senior leader with a unique blend of pharmaceutical, diagnostic & device experience. Broad experience across multiple healthcare specialties including metabolic disease, cardiovascular, ophthal-mology, oncology, tissue engineering and drug delivery.

Mr. Norikazu Eiki Advisor to CM Plus Corporation

In 1979 he joined Ciba-Geigy Japan Co., Ltd. Joined Bayer Japan in 1994, and appointed to Pharmaceutical Director and Shiga Plant Manager. From 2002 to 2006, he was the President and Representative Director, and from 2007 until 2014, he was Representa-tive Director and Chairman of the company. After retiring in 2014, he lives in NJ USA and belongs to the New York Consulting ABPS Group.

Raymond Chan, PharmD ScDMcKinsey & Company, Inc. Japan

18 years of experience in global health care, 9 years in McKinsey, of which 5+ in Japan.Counseled multiple MNC pharma_companies on identifying and evaluating M&A, alliance, and partnership opportunities to grow their business in Japan and globally.

【Speaker】

①Attempt a pharmaceutical applicat ion and export of products②Find a suitable business partner③Develop an appropriate business strategy for the US④Find a bio venture⑤Find a CMO/CRO

Mr. Donald RindellSenior leader with a unique blend of pharmaceutical, diagnostic & device experience including metabolic disease, cardiovascular, ophthalmology, oncology, tissue engineering and drug delivery.

Mr. Rich YangExpert of business development in the fields of biotech, device, diagnostic, and technology enabled health and wellness integration.

Mr. Will ClodfelterSignificant experience in medical device development, financial valuations, market research, and entrepreneurial start-up & turnaround management.

Mr. Christopher RhodesBiopharmaceutical executive with over 25 years R&D leadership experience in pharmaceutical, biotechnology, delivery, and device companies.　

Trust Network

Mr. Norikazu Eiki President and Representative Director of the company, from 2007 until 2014 Representative Director and Chairman of the company. He moved to NJ USA and belongs to the New York Consulting ABPS Group.

Mr. Bruce MyrehnExperience managing projects, teams, functions and sites in the US, Europe, and Japan. Expertise includes engineering, facility delivery, manufac-turing, quality and compliance, inspection readiness, performance improvement, project and alliance management.

h

Fast Pass to the US by Trust Network

Client